These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 22669751)

  • 1. N-TproBNP as biomarker in systemic sclerosis.
    Schioppo T; Artusi C; Ciavarella T; Ingegnoli F; Murgo A; Zeni S; Chighizola C; Meroni PL
    Clin Rev Allergy Immunol; 2012 Dec; 43(3):292-301. PubMed ID: 22669751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of N-terminal pro-brain natriuretic peptide in detecting clinically significant cardiac involvement in systemic sclerosis patients.
    Chighizola C; Meroni PL; Schreiber BE; Coghlan JG; Denton CP; Ong VH
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S81-5. PubMed ID: 22691215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
    Williams MH; Handler CE; Akram R; Smith CJ; Das C; Smee J; Nair D; Denton CP; Black CM; Coghlan JG
    Eur Heart J; 2006 Jun; 27(12):1485-94. PubMed ID: 16682379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro Brain Natriuretic Peptide as predictor of outcome in scleroderma renal crisis.
    Chighizola CB; Pregnolato F; Meroni PL; Denton CP; Ong VH
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):122-128. PubMed ID: 27056603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on biomarker discovery and use in systemic sclerosis.
    Matsushita T; Takehara K
    Expert Rev Mol Diagn; 2017 Sep; 17(9):823-833. PubMed ID: 28730919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers in the management of scleroderma: an update.
    Abignano G; Buch M; Emery P; Del Galdo F
    Curr Rheumatol Rep; 2011 Feb; 13(1):4-12. PubMed ID: 21046295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal pro brain natriuretic peptide: the new cornerstone of cardiovascular assessment in systemic sclerosis.
    Allanore Y; Meune C
    Clin Exp Rheumatol; 2009; 27(3 Suppl 54):59-63. PubMed ID: 19796564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial natriuretic peptide predicts disease progression and digital ulcers development in systemic sclerosis patients.
    Romaniello A; Rubattu S; Gigante A; Simonelli F; Grimaldi MC; D'Angelo A; Alunni D; Sada L; Gasperini ML; Marchitti S; Volpe M; Rosato E
    J Cardiovasc Med (Hagerstown); 2019 Nov; 20(11):771-779. PubMed ID: 31397686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are troponin and B-type natriuretic peptides useful biomarkers for the diagnosis of systemic sclerosis heart involvement? A systematic literature review.
    Ross L; Moxey J; Nikpour M
    Semin Arthritis Rheum; 2021 Feb; 51(1):299-309. PubMed ID: 33434765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs: their involvement in fibrosis pathogenesis and use as diagnostic biomarkers in scleroderma.
    Zhu H; Luo H; Zuo X
    Exp Mol Med; 2013 Sep; 45(9):e41. PubMed ID: 24052166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course.
    Becker MO; Riemekasten G
    Expert Rev Clin Immunol; 2016; 12(2):115-35. PubMed ID: 26558747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement.
    Trombetta AC; Soldano S; Contini P; Tomatis V; Ruaro B; Paolino S; Brizzolara R; Montagna P; Sulli A; Pizzorni C; Smith V; Cutolo M
    Respir Res; 2018 Sep; 19(1):186. PubMed ID: 30249259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment.
    Affandi AJ; Radstake TR; Marut W
    Semin Immunopathol; 2015 Sep; 37(5):475-87. PubMed ID: 26168983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal pro-brain natriuretic peptide in systemic sclerosis: a new cornerstone of cardiovascular assessment?
    Allanore Y; Wahbi K; Borderie D; Weber S; Kahan A; Meune C
    Ann Rheum Dis; 2009 Dec; 68(12):1885-9. PubMed ID: 19054819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I interferon dysregulation in Systemic Sclerosis.
    Skaug B; Assassi S
    Cytokine; 2020 Aug; 132():154635. PubMed ID: 30685202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.
    D'Andrea A; Bellissimo S; Scotto di Uccio F; Vigorito F; Moscato F; Tozzi N; Di Donato M; Citro R; Stisi S; Scherillo M
    Ital Heart J; 2004 Nov; 5(11):831-9. PubMed ID: 15633438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Anti-SNRPA as a Novel Serological Biomarker for Systemic Sclerosis Diagnosis.
    Liu C; Song G; Yan S; He Y; Hu C; Hou Y; Wen X; Li L; Zhang F; Zhu H; Li Y
    J Proteome Res; 2023 Oct; 22(10):3254-3263. PubMed ID: 37639699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contemporary management of systemic sclerosis.
    Eldoma M; Pope J
    Expert Rev Clin Immunol; 2018 Jul; 14(7):573-582. PubMed ID: 29874475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?
    Jimenez SA; Piera-Velazquez S
    Matrix Biol; 2016 Apr; 51():26-36. PubMed ID: 26807760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress in the pathogenesis of systemic scleroderma: An overview.
    Vona R; Giovannetti A; Gambardella L; Malorni W; Pietraforte D; Straface E
    J Cell Mol Med; 2018 Jul; 22(7):3308-3314. PubMed ID: 29664231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.